DMII
Drugs Made In America Acquis
NASDAQ · N/A
$9.99
-0.02 (-0.20%)
Open$9.99
Previous Close$10.01
Day High$9.99
Day Low$9.99
52W High$10.01
52W Low$9.86
Volume—
Avg Volume35.3K
Market Cap655.09M
P/E Ratio—
EPS$-0.01
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 294.92M | 307.45M | 258.08M |
| Net Income | 26.28M | 28.57M | 28.41M |
| Profit Margin | 8.9% | 9.3% | 11.0% |
| EBITDA | 56.56M | 62.55M | 47.02M |
| Free Cash Flow | 16.46M | 18.79M | 20.07M |
| Rev Growth | +17.5% | +6.4% | -5.2% |
| Debt/Equity | 0.63 | 0.87 | 0.69 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.13 | +4.25% | — | 3.64B |
| PICS | Pics Nv | $15.73 | +4.73% | — | 2.04B |
| CCCX | Churchill Capital Corp X-A | $11.66 | +8.57% | — | 606.90M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.53 | +0.10% | 63.0 | 605.14M |
| CEPF | Cantor Equity Partners-Cl A | $10.46 | +0.48% | 364.8 | 597.79M |
| BCSS | Bain Capital Gss Inv- A | $10.16 | +0.00% | — | 593.34M |